Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible. To learn more about BeOne Medicines, please follow our new LinkedIn profile @BeOne Medicines.
Looking for a particular BeiGene employee's phone or email?
The BeiGene annual revenue was $877 million in 2026.
John Oyler is the Founder and CEO of BeiGene.
2,679 people are employed at BeiGene.
BeiGene is based in Cambridge, Massachusetts.
The NAICS codes for BeiGene are [541, 541990, 5419, 54, 54199, 32, 325].
The SIC codes for BeiGene are [729, 873, 87, 72].